Sterna Biologicals, a Clinical stage immunotherapy company, has named Christian Pangratz as its new chief executive officer, it was reported yesterday.
Pangratz was previously working with Vectura Group as senior vice president of business development. He has more than 25 years of life science experience with expertise in the areas of strategic planning, corporate and business development, alliance and project management, new product planning, marketing and sales. He has also held roles for Nektar Therapeutics, Bayer and Pfizer.
Jonas Renz, managing director of Sterna, said, 'Christian is a proven senior executive with extensive leadership experience and an impressive track record. He was instrumental in a number of successful business transformations and high-value transactions across various therapeutic areas that are highly relevant to Sterna.'
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer